Good Afternoon MPIX'ers, The bid sitters sit while the action is on the ask side of things. This is a new twist for us lately. I expect this movement upwards to continue. You may recall two years ago that October was rally month for MPIX, reaching to a high of over eight cents. Now that we have American Capital Ventures working closely with MPIX we can expect fantastic things to take place. The latest PR tells a very interesting situation for us, in this fact " We can now focus on moving the company forward and executing on some of the exciting opportunities that we have been developing over the last several months." This excerpt is taken from the 8-28 PR Victor Siegel states " We are pleased to have engaged ACV, a comprehensive provider of investor relations and communication services to micro-cap companies like ours, to assist us in this very important next step. They will be undoubtedly instrumental in helping us reach our subsequent stage of growth.” I don't know about all of you, but I surely am excited to know that the share price will be going much much higher, sooner than later! What I'm happiest about is the T.E.A.M. aka, The Excellence @ Mindpix No more nonsense of business ethics. They are doing what they say. They are walking the walk, and not talking the walk! Let's hope those blue skies arrive ahead of schedule! Happy days are here again folks! These guys are the real McCoy's!!!! Everyone have a great day!
Krystal Biotech's Upcoming Financial Results Announcement
Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, is gearing up to share its financial results for the third quarter of 2024. This highly anticipated announcement is scheduled for November 4, 2024, before the U.S. markets open, allowing investors to get timely insights into the company's performance.
What to Expect on Financial Reporting Day
The management team at Krystal Bio... Continue Reading
Amicus Therapeutics to Host Conference Call for Q3 ResultsAmicus Therapeutics, a dedicated biotechnology company, has announced its intention to present the financial results for the third quarter of 2024 on November 6, 2024. This conference call will be held at 8:30 a.m. ET, where executives will provide insights into the company's performance and future plans.How to Participate in the CallInvestors and participants eager to join the discussion can easily register fo... Continue Reading
Lithium Ionic's Commitment to Global Sustainability Efforts
Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) has taken a significant step towards sustainability by joining the United Nations Global Compact (UNGC), a prominent initiative aimed at promoting responsible business practices worldwide. This membership showcases Lithium Ionic's dedication to supporting the United Nations Sustainable Development Goals (SDGs) while adhering to the Ten Principles encompassing human righ... Continue Reading
Fractyl Health's Commitment to Metabolic HealthFractyl Health, Inc. (Nasdaq: GUTS), a pioneering company in metabolic therapeutics, is leading the charge in addressing serious health issues like obesity and Type 2 Diabetes (T2D). The company is excited to announce its participation at The Obesity Society’s Annual Meeting during ObesityWeek 2024, where it will present groundbreaking data about its innovative weight maintenance solutions derived from its Revita and Rejuva platforms.... Continue Reading
Gilat's Exciting New Contract with the US Department of Defense
Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is making headlines once again as it secures a significant contract from the US Department of Defense worth over $4 million. This contract has been awarded to Gilat's subsidiary based in the US, DataPath, indicating the trust and reliance military operations place in Gilat's solutions.
Innovative Technology Tailored for Military Needs
The contract s... Continue Reading
Unicycive Therapeutics Shares Key Developments at ASN Kidney Week
Unicycive Therapeutics, Inc. (NASDAQ: UNCY), a leading clinical-stage biotechnology company focused on innovative therapies for kidney disease, recently delivered several impactful presentations at the American Society of Nephrology (ASN) Kidney Week. These presentations highlighted significant advancements in its drug candidates, oxylanthanum carbonate (OLC) and UNI-494.
Significant Findings on Oxylanthanum C... Continue Reading
Understanding WisdomTree's Daily Fund Prices
Investors today are increasingly looking to understand the dynamics of their investments. WisdomTree, a notable player in exchange-traded funds (ETFs), offers a variety of funds that cater to different investment strategies. In this article, we will delve into the latest fund prices for WisdomTree ETFs, providing valuable insights and metrics that can aid in your investment journey.
Highlights of WisdomTree's ETFs
WisdomTr... Continue Reading
Swiss President’s Hope for EU AgreementThe Swiss president has shared a sense of optimism regarding the potential for a finalized deal with the European Union by the end of the year. This comes despite ongoing challenges, particularly surrounding immigration issues. Viola Amherd highlighted that significant progress has already been achieved in other areas, which bodes well for future negotiations.Progress on Key IssuesIn her remarks, President Amherd noted that strid... Continue Reading
CenterPoint Energy Reports Q3 Earnings Amid Growth Aspirations
CenterPoint Energy (NYSE: CNP) showcased its financial performance for the third quarter, revealing earnings that didn't meet analyst expectations. Despite this shortfall, the company maintained its outlook for the full year, suggesting a commitment to growth and stability. Interestingly, the company's stock saw a slight uptick of 1% following the earnings release, signaling investor resilience and a belief in the company... Continue Reading
Bank of Hawaii Surpasses Q3 Earnings Expectations
Bank of Hawaii Corporation (NYSE: BOH) has recently released its third quarter earnings report, showcasing a remarkable performance that exceeded analyst expectations. The bank's net income rose significantly, marking an 18.4% increase compared to the previous quarter.
Impressive Financial Results
During the third quarter, Bank of Hawaii reported a net income of $40.4 million, translating to $0.93 per diluted share. An... Continue Reading